DIAMOND BIOTECHNOLOGY CO., LTD Diamond Biotechnology Co., Ltd Share Price
Equities
6815
TW0006815004
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.7 TWD | -2.07% |
|
-4.47% | +2.05% |
| Sales 2022 | 435M 13.51M 1.06B | Sales 2023 | 616M 19.15M 1.5B | Capitalization | 2.42B 75.08M 5.88B |
|---|---|---|---|---|---|
| Net income 2022 | 33M 1.03M 80.27M | Net income 2023 | 46M 1.43M 112M | EV / Sales 2022 | 2.22 x |
| Net Debt 2022 | 98.76M 3.07M 240M | Net Debt 2023 | 258M 8.01M 627M | EV / Sales 2023 | 4.34 x |
| P/E ratio 2022 |
25.9
x | P/E ratio 2023 |
51.7
x | Employees | - |
| Yield 2022 |
0.35% | Yield 2023 |
0.2% | Free-Float | 94.14% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.07% | ||
| 1 week | -4.47% | ||
| Current month | -9.67% | ||
| 1 month | -9.94% | ||
| 3 months | +2.28% | ||
| 6 months | +2.05% | ||
| Current year | +2.05% |
1 week
88.00
94.20
1 month
88.00102.00
Current year
83.20108.50
1 year
74.10150.57
3 years
21.60150.57
5 years
21.60150.57
10 years
21.60150.57
| Managers | Title | Age | Since |
|---|---|---|---|
Chia Hsien Hsieh
CEO | Chief Executive Officer | - | 25/11/14 |
Jou Fang Wang
DFI | Director of Finance/CFO | - | 27/10/19 |
Hao Wen Cheng
AUD | Comptroller/Controller/Auditor | - | 07/04/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wei Fang Hsieh
BRD | Director/Board Member | - | 27/06/17 |
Yan Hui Tsai
BRD | Director/Board Member | - | 26/11/17 |
Fan Chuan Shih
BRD | Director/Board Member | - | 07/01/21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/05/24 | 89.7 | -2.07% | 119,077 |
| 27/05/24 | 91.6 | -0.87% | 57,090 |
| 24/05/24 | 92.4 | -0.86% | 109,543 |
| 23/05/24 | 93.2 | -0.32% | 66,252 |
| 22/05/24 | 93.5 | +0.86% | 34,008 |
End-of-day quote Taipei Exchange, May 27, 2024
More quotes
Diamond Biotechnology Co Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of skin care products and medical equipment. The main products are skin care products and medical equipment. The skin care products include facial masks, lotions, creams, essences and others, which are mainly used for facial skin care and cleaning. The medical equipment includes wires, sonic wave medical equipment, radio wave medical equipment, frozen fat reduction medical equipment and other medical equipment, as well as micro plastic surgery consumables such as botulinum and collagen injections, which are mainly used to improve skin wrinkles and sagging. The Company is also engaged in the provision of medical equipment leasing services and medical beauty management consulting services. The Company operates within the domestic market and to overseas markets.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.05% | 78.21M | |
| -7.38% | 181B | |
| -0.46% | 108B | |
| -6.98% | 66.12B | |
| +2.65% | 50.65B | |
| +5.27% | 43.11B | |
| +3.49% | 40.74B | |
| +19.92% | 31.6B | |
| +16.38% | 25.56B | |
| -7.00% | 24.16B |
- Stock Market
- Equities
- 6815 Stock
